Safety data, including from LTE
Visit the website to learn more. U.S. Full Prescribing Information | Important Safety Information . . . INDICATION SOTYKTU® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Limitations of Use: SOTYKTU is not recommended for use in combination with other potent immunosuppressants. Explore the safety […]
Efficacy data from LTE
Visit the website to learn more. U.S. Full Prescribing Information | Important Safety Information . . . INDICATION SOTYKTU is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Limitations of Use: SOTYKTU is not recommended for use in combination with other potent immunosuppressants. SELECT IMPORTANT SAFETY INFORMATION […]
PASI 90 and Scalp Data
Visit the website to learn more. U.S. Full Prescribing Information | Important Safety Information . . . INDICATION SOTYKTU is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Limitations of Use: SOTYKTU is not recommended for use in combination with other potent immunosuppressants. SOTYKTU showed superior […]
Dosing Information
Real Patient Photos (Outside of Clinical Trials)
Patient Profiles
Resources & Support
Key Opinion Leader Videos
Mechanism of Action Video